Medicare Enrolled
Dr. Michael Lewitton, M.D.
Urology Physician · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lewitton from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lewitton?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lewitton
Dr. Michael Lewitton is an urology physician in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lewitton performed 9,418 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lewitton received a total of $15,063 from 81 pharmaceutical and/or device companies across 616 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lewitton is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 10% volume in TX
$15,063 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗9,418
Medicare services
Top 10% in TX for urology physician
Not available
Unique patients (not deduplicated)
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,400 | $18 | $24 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,326 | $2 | $2 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,144 | $46 | $65 |
| Leuprolide injectable, camcevi, 1 mg | 966 | $62 | $91 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
963 | $8 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
905 | $87 | $138 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
491 | $66 | $94 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
292 | $8 | $12 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
136 | $119 | $176 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
131 | $165 | $262 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 72 | $145 | $187 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
68 | $0 | $1 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
60 | $31 | $45 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
58 | $11 | $16 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
57 | $93 | $268 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
55 | $24 | $42 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
34 | $26 | $35 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
31 | $59 | $88 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
31 | $6 | $16 |
| Insertion of temporary bladder tube | 30 | $37 | $47 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
29 | $126 | $198 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
25 | $89 | $111 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
22 | $83 | $121 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
18 | $2,178 | $3,780 |
| Waterjet prostate destruction via urethra A procedure that uses a high-pressure water jet to destroy prostate tissue, accessed through the urethra. |
17 | $542 | $1,905 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
17 | $57 | $171 |
| Implantable tissue marker, each A small marker is implanted into tissue to serve as a reference point for future medical imaging or procedures. |
15 | $68 | $200 |
| 3D radiographic procedure with computerized image postprocessing A radiographic imaging procedure that creates three-dimensional images using computerized processing of the captured data. |
14 | $34 | $42 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
11 | $62 | $77 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$15,063
Total received (2018-2024)
Avg $2,152/year across 7 years
Top 14% in TX for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
81
Companies
616
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,311
2023
$2,506
2022
$2,433
2021
$1,126
2020
$1,076
2019
$3,083
2018
$1,528
Payments by company (2024)
BIOTISSUE HOLDINGS INC.
$380
Boston Scientific Corporation
$308
Myriad Genetic Laboratories, Inc.
$286
Ferring Pharmaceuticals Inc.
$244
Astellas Pharma US Inc
$217
Sumitomo Pharma America, Inc.
$207
PROCEPT BioRobotics Corporation
$200
Medtronic, Inc.
$163
ABBVIE INC.
$155
Janssen Biotech, Inc.
$137
Antares Pharma, Inc.
$99
PROGENICS PHARMACEUTICALS, INC.
$95
Endo USA, Inc.
$89
Ambu Inc.
$71
Baxter Healthcare
$61
Checkpoint Surgical, Inc
$57
HealthTronics Stone Solutions, LLC
$49
Laborie Medical Technologies Corp.
$48
Avanos Medical
$38
Blue Earth Diagnostics Limited
$36
Bayer Healthcare Pharmaceuticals Inc.
$32
Teleflex LLC
$31
Axonics, Inc.
$28
PFIZER INC.
$27
SUN PHARMACEUTICAL INDUSTRIES INC.
$27
Dendreon Pharmaceuticals LLC
$26
IMMUNITYBIO, INC.
$24
ACCORD HEALTHCARE, INC.
$24
Tempus AI, Inc
$23
Cook Medical LLC
$21
Olympus America Inc.
$20
Kerecis Limited
$20
Provepharm Inc.
$19
UROGEN PHARMA, INC.
$18
Tolmar, Inc.
$16
Amgen Inc.
$14
Top 3 companies account for 29.4% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$1,887
Astellas Pharma US Inc
$1,210
Janssen Biotech, Inc.
$1,081
PFIZER INC.
$900
ABBVIE INC.
$753
Myriad Genetic Laboratories, Inc.
$721
BOSTON SCIENTIFIC CORPORATION
$681
Antares Pharma, Inc.
$539
Endo Pharmaceuticals Inc.
$442
Amgen Inc.
$441
Ferring Pharmaceuticals Inc.
$396
Sumitomo Pharma America, Inc.
$382
BIOTISSUE HOLDINGS INC.
$380
Olympus America Inc.
$322
Progenics Pharmaceuticals, Inc.
$274
Allergan Inc.
$260
Myovant Sciences Inc.
$240
ConvaTec Inc.
$238
PROCEPT BioRobotics Corporation
$220
Dendreon Pharmaceuticals LLC
$185
NeoTract Inc.
$182
Bayer HealthCare Pharmaceuticals Inc.
$164
Medtronic, Inc.
$163
Allergan, Inc.
$139
Axonics, Inc.
$135
AbbVie, Inc.
$132
Ambu Inc.
$124
Bayer Healthcare Pharmaceuticals Inc.
$117
Smith+Nephew, Inc.
$116
Terumo Medical Corporation
$103
Aytu BioScience, Inc
$98
TOLMAR Pharmaceuticals, Inc.
$97
ACCORD HEALTHCARE, INC.
$96
PROGENICS PHARMACEUTICALS, INC.
$95
Tolmar, Inc.
$90
Endo USA, Inc.
$89
Blue Earth Diagnostics Limited
$87
UROVANT SCIENCES INC
$83
Axonics Modulation Technologies, Inc.
$74
Laborie Medical Technologies Corp.
$64
AbbVie Inc.
$64
UroGen Pharma, Inc.
$63
Baxter Healthcare
$61
Teleflex LLC
$58
Checkpoint Surgical, Inc
$57
Merck Sharp & Dohme LLC
$56
Acerus Pharmaceuticals Corporation
$53
HealthTronics Stone Solutions, LLC
$49
AstraZeneca Pharmaceuticals LP
$48
Supernus Pharmaceuticals, Inc.
$42
Coloplast Corp
$39
ABC Home Medical Supply, Inc.
$38
Avanos Medical
$38
Mission Pharmacal Company
$36
Alexion Pharmaceuticals, Inc.
$32
Novartis Pharmaceuticals Corporation
$30
Janssen Pharmaceuticals, Inc
$29
GENZYME CORPORATION
$27
SUN PHARMACEUTICAL INDUSTRIES INC.
$27
Avadel Specialty Pharmaceuticals, LLC
$26
180 Medical, Inc.
$25
Merck Sharp & Dohme Corporation
$24
IMMUNITYBIO, INC.
$24
Tempus AI, Inc
$23
ACELL, INC.
$21
Retrophin, Inc.
$21
Cook Medical LLC
$21
Pacira Pharmaceuticals Incorporated
$21
Kerecis Limited
$20
RGH Enterprises, Inc.
$19
Provepharm Inc.
$19
DENTSPLY IH Inc.
$19
Abbott Laboratories
$19
UROGEN PHARMA, INC.
$18
AKRIMAX PHARMACEUTICALS, LLC
$15
Baudax Bio Inc.
$14
Travere Therapeutics, Inc.
$14
BioTissue Holdings, Inc.
$14
EDAP TECHNOMED INC
$12
Renovia Inc
$12
NxThera, Inc.
$11
Top 3 companies account for 27.7% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AFINITOR · ALTIS · AMBICOR · AMS 700 CXR RTE KIT · ANJESO · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Androgel · Axium INS DRG IPG · Axonics · Axonics r-SNM System · Axumin · Azur CX Detachable · BLUDIGO · BOTOX · BOTOX THERAPEUTIC · BRAC CDx · BRACANALYSIS CDX · BRACAnalysis CDx · CAMCEVI · CERVIDIL · CLENPIQ · COOK · Checkpoint Stimulators · Dornier MedTech · EDEX · ELIGARD · ERLEADA · EVENITY · EXPAREL · Erleada · FIRMAGON · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · GENERAL - BPH · GENERAL - KIDNEY STONE DISEASE · GENERAL BPH · GENTLECATH · General - BPH · INTERSTIM · JELMYTO · JEVTANA · KEYTRUDA · Kerecis Omega3 SurgiClose · LITHOVUE · LUPRON DEPOT · LYNPARZA · Leva Pelvic Floor Trainer · LoFric · Lupron · Lupron Depot · MYRBETRIQ · Moses 550 DFL · Myrbetriq · NEOX · NOCDURNA · Natesto · Noctiva · Nubeqa · ON-Q* PUMP AND ACCESSORIES · ORGOVYX · OTREXUP · Olympus Laser Devices · Optilume BPH Drug Coated Balloon Catheter · Otrexup · PERCLOT · POSLUMA · PREMARIN · PROLARIS · PROVENGE · PYLARIFY · Prolia · REZUM · Rezum · Rezum Generator · STRAVIX PL · SpaceOAR System · SpaceOAR VUE System - 10mL · Swiss LithoClast Triology · TITAN · TLANDO · TOVIAZ · ThunderBeat · ULTOMIRIS · UROLIFT · Uribel · UroLift · VESICARE · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
198
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lewitton is a clinical cardiology specialist, with above-average Medicare volume (top 10% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lewitton experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Lewitton performed 2,400 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lewitton receive payments from pharmaceutical companies?
Yes. Dr. Lewitton received a total of $15,063 from 81 companies across 616 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lewitton's costs compare to other urology physicians in Houston?
Dr. Lewitton's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lewitton) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Houston
Browse urology physicians in Houston ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology